Science & Research
Kairos Pharma Ltd. Reports Positive Safety Results in Phase 2 Study of Prostate Cancer Drug ENV-105
Kairos Pharma Ltd. announces favorable interim safety results from its Phase 2 trial of ENV-105 for metastatic castration-resistant prostate cancer, marking a significant step forward in cancer therapy.
Curebound Aims to Accelerate Cancer Cures Amid NIH Funding Cuts
Curebound, under the leadership of COO Karen Hooper, is intensifying efforts to fund innovative cancer research, especially critical in light of recent NIH funding cuts, to accelerate cures within our lifetime.
Alicia Kali's Test for Sentience Marks a New Era in AI Development
Alicia Kali introduces a groundbreaking Test for Sentience in AI, significantly reducing data storage needs by 90% and setting a new standard for machine cognition.
Lorati's Nano-Emulsion Offers New Hope for Stroke Recovery
Lorati Co., Ltd. introduces a natural, mineral-based nano-emulsion therapy that promises a non-invasive solution for full recovery from both hemorrhagic and ischemic strokes, marking a significant advancement in stroke treatment.
GeoVax to Showcase Vaccine and Cancer Therapy Progress at Emerging Growth Conference
GeoVax Labs, Inc. will present updates on its GEO-MVA, GEO-CM04S1, and Gedeptin® programs at the Emerging Growth Conference, highlighting advancements in vaccine development and cancer therapy.
NanoViricides Advances MPox Treatment with Adaptive Clinical Trial Design
NanoViricides, Inc. nears finalization of an adaptive clinical trial protocol for NV-387, a potential first-in-class treatment for MPox, highlighting its significance amid limited effective therapies.
ESGold Corp. Reveals District-Scale Potential at Montauban Gold-Silver Project
ESGold Corp.'s latest ANT survey at the Montauban Gold-Silver Project indicates a significant, deep-reaching mineralized system, suggesting the site could host a district-scale VMS system with substantial long-term mining potential.
New Initiative Aims to Improve Surgical Outcomes for Hemorrhagic Stroke Patients
The American Heart Association launches a nationwide initiative to standardize and improve surgical treatments for hemorrhagic strokes, which are responsible for over 40% of stroke-related deaths despite accounting for only 13% of cases.
Sino Biological Introduces ProPure™ Endotoxin-Free Proteins, Enhancing Research and Therapeutic Development
Sino Biological US, Inc. launches ProPure™, a line of ultra-pure, endotoxin-free recombinant proteins produced in the USA, setting a new industry standard for research and therapeutic applications.
New Study Reveals Hidden Chemical Threats Are Reshaping Ecosystems
A groundbreaking study highlights the complex, nonlinear impacts of chemical pollution on ecosystems, proposing a new framework for early detection and prevention of irreversible damage.
ESGold Corp. Reveals District-Scale Mineralization Potential at Montauban Project
ESGold Corp.'s recent survey at the Montauban Project in Quebec uncovers deep geological structures indicating significant mineralization potential, marking a pivotal step in exploration.
Calidi Biotherapeutics Featured in NetworkNewsWire Spotlight on Genetic Medicines
Calidi Biotherapeutics' innovative approach to treating hard-to-treat cancers with engineered viruses is highlighted in a NetworkNewsWire editorial, showcasing its potential to transform cancer treatment and address autoimmune disorders.
SeaStar Medical's QUELIMMUNE Recognized by National Kidney Foundation for Innovation in Pediatric AKI Treatment
SeaStar Medical's QUELIMMUNE device, designed to treat pediatric acute kidney injury, has been awarded the 2025 Corporate Innovator Award by the National Kidney Foundation, highlighting its potential to significantly reduce mortality rates and improve quality of life for affected children.
Global Ocean Analysis Offers Cost-Effective Alternative for Seafloor Positioning
A study finds that global ocean analysis products can replace expensive in-situ sound speed measurements for precise seafloor positioning, potentially reducing costs and logistical challenges in marine geodetic surveys.
Creative Biolabs Advances ADC Therapy with Precision Toxin Design and Pharmacokinetic Analysis
Creative Biolabs highlights the intricate balance and design behind ADC therapy, emphasizing the importance of toxin precision and pharmacokinetic studies for effective cancer treatment.
Study Links Traumatic Brain Injuries to Increased Brain Cancer Risk in Veterans
A recent study published in JAMA Network reveals that military veterans with traumatic brain injuries face a significantly higher risk of developing brain cancer, highlighting the urgent need for advanced treatments and preventive measures.
Fifty 1 Labs and UAV Corp Complete Historic REVIVE Trial, Pioneering Long COVID Treatment
Fifty 1 Labs, Inc. and UAV Corp have successfully completed the REVIVE Adaptive Platform Trial, marking a significant advancement in the treatment of Long COVID and positioning the companies for growth in the functional medicine market.
Aston Bay Holdings Reports Promising Initial Results from Storm Copper Project
Aston Bay Holdings Ltd. announces encouraging preliminary drill and geophysical results from its Storm Copper Project in Nunavut, highlighting the potential for significant copper mineralization.
Intelligent Bio Solutions Inc. to Showcase Fingerprint Sweat PK Study at ADLM 2025 Clinical Lab Expo
Intelligent Bio Solutions Inc. will present its pharmacokinetic study data at the ADLM 2025 Clinical Lab Expo, highlighting the reliability of fingerprint sweat as a non-invasive diagnostic tool for drug screening.
Jupiter Neurosciences Advances in Treating Neuroinflammation and Aging with JOTROL™ and Nugevia™
Jupiter Neurosciences Inc. is making strides in treating central nervous system disorders and tapping into the longevity market with its innovative products JOTROL™ and Nugevia™, highlighting the potential to combat aging and neuroinflammation.
CNS Pharmaceuticals Inc. Showcases Lead Cancer Treatment Program in Virtual CEO Segment
CNS Pharmaceuticals Inc. (NASDAQ: CNSP) emphasizes its lead cancer treatment program during a virtual CEO segment, highlighting potential advancements in brain and central nervous system cancer therapies.
Creative Biolabs Enhances Drug Delivery with LipoDrive™ Platform
Creative Biolabs introduces the LipoDrive™ platform, a cutting-edge solution for liposomal drug delivery, addressing the growing demand for precision in biopharmaceutical formulations.
New Study Links Cannabis Use to Enhanced Sexual Desire and Reduced Anxiety
Recent research indicates cannabis use may increase sexual interest and arousal while decreasing anxiety related to sexual activity, highlighting potential benefits of marijuana products.
Ninth Annual New York City Math Festival to Illuminate Fosun Plaza with Interactive Learning
The National Museum of Mathematics (MoMath) and Fosun will host the ninth annual New York City Math Festival, offering free, family-friendly activities that highlight the fun and importance of mathematics.
University of Sydney Researchers Discover Potential Breakthrough in Parkinson's Treatment
A preclinical study by University of Sydney researchers has successfully reversed Parkinson's-like symptoms in mice by targeting a malfunctioning protein, offering hope for future human treatments.
Quantum BioPharma Submits MS Drug Candidate to UK's ILAP Program
Quantum BioPharma Ltd. advances its multiple sclerosis treatment, Lucid-MS, through the UK's Innovative Licensing and Access Pathway, aiming to accelerate patient access to this innovative therapy.
Calidi Biotherapeutics' Genetic Medicine Platform Featured in Editorial for Cancer Treatment Innovation
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been highlighted in an editorial for its precision genetic medicine platform, offering a novel approach to targeting cancer tumors amidst rising global diagnoses.
Calidi Biotherapeutics' Genetic Medicine Platform Highlighted for Potential Cancer Breakthrough
Calidi Biotherapeutics Inc. (NYSE American: CLDI) has been featured in an editorial for its precision genetic medicine platform, which could revolutionize cancer treatment by targeting tumors with engineered viruses.
NeuroEyeCoach Study Highlights Benefits for Vision Rehabilitation in Home and Clinic Settings
A new study on NovaVision's NeuroEyeCoach demonstrates significant improvements in visual search performance for patients, whether used at home or in a clinic, supporting its role in vision rehabilitation.
Study Reveals Environmental Contaminant 6-PPDQ Disrupts Citric Acid Cycle in C. elegans
Research highlights the potential environmental and human health risks posed by 6-PPDQ, a contaminant derived from tire antioxidants, through its disruption of the citric acid cycle in C. elegans.